POLQ immunostaining behaves as a prognostic factor for pancreatic carcinoma
Our results indicate that POLQ is an independent prognostic factor in pancreatic cancer when analyzed by immunostaining, which is in agreement with the results shown by the <i>POLQ</i> gene expression analysis (GEPIA).
Authors
- Luis Díez-Valladares
- Elia Pérez-Aguirre
- Alejandra García‐Botella (ORCID: https://orcid.org/0000-0003-4773-3810)
- Yuliia Fatych (ORCID: https://orcid.org/0000-0003-3995-498X)
- Sofía de la Serna (ORCID: https://orcid.org/0000-0002-0046-6236)
- Jesús García‐Foncillas
- Pedro A. Mateos‐Gómez (ORCID: https://orcid.org/0000-0002-5539-2289)
- Laura del Puerto‐Nevado
- Javier Martínez‐Useros (ORCID: https://orcid.org/0000-0001-9007-828X)
- Arancha Cebrián (ORCID: https://orcid.org/0000-0002-6260-1376)
- María Jesús Fernández‐Aceñero (ORCID: https://orcid.org/0000-0002-2439-3553)
Institutions
- Universidad de Alcalá (ES)
- Hospital Clínico San Carlos (ES)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-10-07
- DOI
- https://doi.org/10.3389/fonc.2024.1433179
- Citations
- 3
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- Comunidad de Madrid